The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Self-assembled RNA-triple-helix hydrogel scaffold for microRNA modulation in the tumour microenvironment
Open accessAbstract
The therapeutic potential of miRNA (miR) in cancer is limited by the lack of efficient delivery vehicles. Here, we show that a self-assembled dual-colour RNA-triple-helix structure comprising two miRNAs—a miR mimic (tumour suppressor miRNA) and an antagomiR (oncomiR inhibitor)—provides outstanding capability to synergistically abrogate tumours. Conjugation of RNA triple helices to dendrimers allows the formation of stable triplex nanoparticles, which form an RNA-triple-helix adhesive scaffold upon interaction with dextran aldehyde, the latter able to chemically interact and adhere to natural tissue amines in the tumour. We also show that the self-assembled RNA-triple-helix conjugates remain functional in vitro and in vivo, and that they lead to nearly 90% levels of tumour shrinkage two weeks post-gel implantation in a triple-negative breast cancer mouse model. Our findings suggest that the RNA-triple-helix hydrogels can be used as an efficient anticancer platform to locally modulate the expression of endogenous miRs in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells
Nassirpour, R., Mehta, P. P., Baxi, S. M., & Yin, M.-J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062170 · Cited by 93
RetractedRegulation of microRNA biogenesis
Ha, M., & Kim, V. N. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3838 · Cited by 5,462
Foulkes, W. D., Smith, I. E., & Reis-Filho, J. S. (2010) · New England Journal of Medicine · doi:10.1056/nejmra1001389 · Cited by 4,157
Regulated portals of entry into the cell
Conner, S. D., & Schmid, S. L. (2003) · Nature · doi:10.1038/nature01451 · Cited by 3,805
Non-viral vectors for gene-based therapy
Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
Miller, K., Wang, M., Gralow, J., Dickler, M., Cobleigh, M., Perez, E. A., Shenkier, T., Cella, D., & Davidson, N. E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072113 · Cited by 3,081
Iversen, T.-G., Skotland, T., & Sandvig, K. (2011) · Nano Today · doi:10.1016/j.nantod.2011.02.003 · Cited by 1,239
Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery
Lee, H., Lytton-Jean, A. K. R., Chen, Y., Love, K. T., Park, A. I., Karagiannis, E. D., Sehgal, A., Querbes, W., Zurenko, C. S., Jayaraman, M., et al. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.73 · Cited by 1,169
Therapeutic targeting of microRNAs: current status and future challenges
Li, Z., & Rana, T. M. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4359 · Cited by 1,033
Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer
Sparano, J. A., Wang, M., Martino, S., Jones, V., Perez, E. A., Saphner, T., Wolff, A. C., Sledge, G. W., Wood, W. C., & Davidson, N. E. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707056 · Cited by 997
MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy
Kasinski, A. L., & Slack, F. J. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3166 · Cited by 936
MicroRNA silencing for cancer therapy targeted to the tumour microenvironment
Cheng, C. J., Bahal, R., Babar, I. A., Pincus, Z., Barrera, F., Liu, C., Svoronos, A., Braddock, D. T., Glazer, P. M., Engelman, D. M., et al. (2015) · Nature · doi:10.1038/nature13905 · Cited by 823
The emerging field of RNA nanotechnology
Guo, P. (2010) · Nature Nanotechnology · doi:10.1038/nnano.2010.231 · Cited by 718
In vivo delivery of miRNAs for cancer therapy: Challenges and strategies
Chen, Y., Gao, D.-Y., & Huang, L. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.009 · Cited by 672
Anand, S., Majeti, B. K., Acevedo, L. M., Murphy, E. A., Mukthavaram, R., Scheppke, L., Huang, M., Shields, D. J., Lindquist, J. N., Lapinski, P. E., et al. (2010) · Nature Medicine · doi:10.1038/nm.2186 · Cited by 517
Nanoparticles Modified With Tumor-targeting scFv Deliver siRNA and miRNA for Cancer Therapy
Chen, Y., Zhu, X., Zhang, X., Liu, B., & Huang, L. (2010) · Molecular Therapy · doi:10.1038/mt.2010.136 · Cited by 515
Self-assembled RNA interference microsponges for efficient siRNA delivery
Lee, J. B., Hong, J., Bonner, D. K., Poon, Z., & Hammond, P. T. (2012) · Nature Materials · doi:10.1038/nmat3253 · Cited by 494
Lipid‐based nanotherapeutics for siRNA delivery
Schroeder, A., Levins, C. G., Cortez, C., Langer, R., & Anderson, D. G. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02189.x · Cited by 447
Shu, D., Shu, Y., Haque, F., Abdelmawla, S., & Guo, P. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.105 · Cited by 435
Adjuvant Dose-Dense Chemotherapy in Breast Cancer: Standard of Care in High-Risk Patients
Möbus, V. (2016) · Breast Care · doi:10.1159/000444004 · Cited by 354
The triple helix: 50 years later, the outcome
Duca, M., Vekhoff, P., Oussedik, K., Halby, L., & Arimondo, P. B. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn493 · Cited by 341
Jones, A. T. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00062.x · Cited by 315
Past, Present, and Future Challenges in Breast Cancer Treatment
Sledge, G. W., Mamounas, E. P., Hortobagyi, G. N., Burstein, H. J., Goodwin, P. J., & Wolff, A. C. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.4139 · Cited by 277
Shu, D., Li, H., Shu, Y., Xiong, G., Carson, W. E., Haque, F., Xu, R., & Guo, P. (2015) · ACS Nano · doi:10.1021/acsnano.5b02471 · Cited by 270
Multimeric small interfering ribonucleic acid for highly efficient sequence-specific gene silencing
Mok, H., Lee, S. H., Park, J. W., & Park, T. G. (2010) · Nature Materials · doi:10.1038/nmat2626 · Cited by 238
Triplex DNA: fundamentals, advances, and potential applications for gene therapy
Chan, P. P., & Glazer, P. M. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050112 · Cited by 229
Ultrastable synergistic tetravalent RNA nanoparticles for targeting to cancers
Haque, F., Shu, D., Shu, Y., Shlyakhtenko, L. S., Rychahou, P. G., Mark Evers, B., & Guo, P. (2012) · Nano Today · doi:10.1016/j.nantod.2012.06.010 · Cited by 193
MicroRNA Delivery by Cationic Lipoplexes for Lung Cancer Therapy
Wu, Y., Crawford, M., Yu, B., Mao, Y., Nana-Sinkam, S. P., & Lee, L. J. (2011) · Molecular Pharmaceutics · doi:10.1021/mp2002076 · Cited by 172
Oncosuppressive role of p53‐induced miR‐205 in triple negative breast cancer
Piovan, C., Palmieri, D., Di Leva, G., Braccioli, L., Casalini, P., Nuovo, G., Tortoreto, M., Sasso, M., Plantamura, I., Triulzi, T., et al. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.03.003 · Cited by 166
Mittal, A., Chitkara, D., Behrman, S. W., & Mahato, R. I. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.053 · Cited by 161
Endocytic Mechanisms of Graphene Oxide Nanosheets in Osteoblasts, Hepatocytes and Macrophages
Linares, J., Matesanz, M. C., Vila, M., Feito, M. J., Gonçalves, G., Vallet-Regí, M., Marques, P. A. A. P., & Portolés, M. T. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am5031598 · Cited by 159
Kitchens, K. M., Kolhatkar, R. B., Swaan, P. W., & Ghandehari, H. (2008) · Molecular Pharmaceutics · doi:10.1021/mp700089s · Cited by 157
Conde, J., Oliva, N., & Artzi, N. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421229112 · Cited by 139
Self-citationHydrogel Doped with Nanoparticles for Local Sustained Release of siRNA in Breast Cancer
Segovia, N., Pont, M., Oliva, N., Ramos, V., Borrós, S., & Artzi, N. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201400235 · Cited by 139
Self-citationYin, P. T., Shah, B. P., & Lee, K. (2014) · Small · doi:10.1002/smll.201400963 · Cited by 135
Systemic delivery of miR-126 by miRNA-loaded Bubble liposomes for the treatment of hindlimb ischemia
Endo‐Takahashi, Y., Negishi, Y., Nakamura, A., Ukai, S., Ooaku, K., Oda, Y., Sugimoto, K., Moriyasu, F., Takagi, N., Suzuki, R., et al. (2014) · Scientific Reports · doi:10.1038/srep03883 · Cited by 115
Nucleic Acid-Gold Nanoparticle Conjugates as Mimics of microRNA
Hao, L.-L., Patel, P. C., Alhasan, A. H., Giljohann, D., & Mirkin, C. (2011) · Small · doi:10.1002/smll.201101018 · Cited by 107
Polymer nanoparticle-mediated delivery of microRNA inhibition and alternative splicing
Cheng, C. J., & Saltzman, W. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300081s · Cited by 92
Conde, J., Ambrosone, A., Hernández, Y., Tian, F., McCully, M., Berry, C. C., Baptista, P. V., Tortiglione, C., & de la Fuente, J. M. (2015) · Nano Today · doi:10.1016/j.nantod.2015.06.008 · Cited by 91
Self-citationOliva, N., Solanes, M. C., Beckerman, M., Seliktar, S., Hayward, A. M., Stanley, J., Parry, N. M., Edelman, E. R., & Artzi, N. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa1616 · Cited by 79
Self-citationConde, J., Edelman, E. R., & Artzi, N. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.09.003 · Cited by 71
Self-citationTargeting miRNA-based medicines to cystic fibrosis airway epithelial cells using nanotechnology
Cryan, S., McKiernan, P. J., Cunningham, & Greene, C. M. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s47551 · Cited by 64
Natural Tissue Microenvironmental Conditions Modulate Adhesive Material Performance
Oliva, N., Shitreet, S., Abraham, E., Stanley, B., Edelman, E. R., & Artzi, N. (2012) · Langmuir · doi:10.1021/la303155p · Cited by 40
Self-citationSilencing of HIV by hairpin‐loop‐structured DNA oligonucleotide
Moelling, K., Abels, S., Jendis, J., Matskevich, A. A., & Heinrich, J. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.05.033 · Cited by 30
Cited by
Advances in Biomaterials for Drug Delivery
Fenton, O. S., Olafson, K. N., Pillai, P. S., Mitchell, M. J., & Langer, R. (2018) · Advanced Materials · doi:10.1002/adma.201705328 · Cited by 855
Mendes, B. B., Conniot, J., Avital, A., Yao, D., Jiang, X., Zhou, X., Sharf-Pauker, N., Xiao, Y., Adir, O., Liang, H., et al. (2022) · Nature Reviews Methods Primers · doi:10.1038/s43586-022-00104-y · Cited by 719
Self-citationChemically Modified Biopolymers for the Formation of Biomedical Hydrogels
Muir, V. G., & Burdick, J. A. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00923 · Cited by 604
Strategies, design, and chemistry in siRNA delivery systems
Dong, Y., Siegwart, D. J., & Anderson, D. G. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.05.004 · Cited by 572
Conde, J., Oliva, N., Zhang, Y., & Artzi, N. (2016) · Nature Materials · doi:10.1038/nmat4707 · Cited by 449
Self-citation
Metadata
- Authors
- Conde, J., Oliva, N., Atilano, M., Song, H. S., & Artzi, N.
- Venue
- Nature Materials
- Published
- 2015-12-07
- Volume
- 15
- Issue
- 3
- Pages
- 353-363
- ISSN
- 1476-1122 (ISSN-L)
- 1476-4660
- OpenAlex
- W2190204638
- Cited by
- 283
- References
- 44
- FWCI
- 11.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.